# Carter BloodCare – FDA Inspection, Oct 15, 2009

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare/78d53cfc-2229-41fb-9d3e-5075c73f5b33
Source feed: FDA_Inspections

> FDA inspection 620063 of Carter BloodCare, October 15, 2009. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 620063
- Company Name: Carter BloodCare
- Inspection Date: 2009-10-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1272556 - 2025-06-05
- FDA Inspection 1227222 - 2024-01-11
- FDA Inspection 1088131 - 2019-04-05
- FDA Inspection 1029042 - 2017-08-02
- [FDA Inspection 871589 - 2014-03-17](https://www.keypedia.com/records/fda_inspections/carter-bloodcare/c8eeb1fc-8e1d-42e0-a8a6-76e1186ddb51)

Company: https://www.keypedia.com/companies/carter-bloodcare/1906a188-d50d-4477-9ca3-3de9d82111e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d